219 related articles for article (PubMed ID: 21160767)
1. Telomere function in colorectal cancer.
Frías C; Morán A; de Juan C; Ortega P; Fernández-Marcelo T; Sánchez-Pernaute A; Torres AJ; Díaz-Rubio E; Benito M; Iniesta P
World J Gastrointest Oncol; 2009 Oct; 1(1):3-11. PubMed ID: 21160767
[TBL] [Abstract][Full Text] [Related]
2. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
3. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
4. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
5. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
7. Telomeres and telomerase in the clinical management of colorectal cancer.
Piñol-Felis C; Fernández-Marcelo T; Viñas-Salas J; Valls-Bautista C
Clin Transl Oncol; 2017 Apr; 19(4):399-408. PubMed ID: 27761787
[TBL] [Abstract][Full Text] [Related]
8. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
Fernández-Marcelo T; Gómez A; Pascua I; de Juan C; Head J; Hernando F; Jarabo JR; Calatayud J; Torres-García AJ; Iniesta P
J Exp Clin Cancer Res; 2015 Aug; 34(1):78. PubMed ID: 26250468
[TBL] [Abstract][Full Text] [Related]
9. Telomere length and hTERT expression in patients with colorectal carcinoma.
Rosenberg R; Gertler R; Stricker D; Lassmann S; Werner M; Nekarda H; Siewert JR
Recent Results Cancer Res; 2003; 162():177-81. PubMed ID: 12790332
[TBL] [Abstract][Full Text] [Related]
10. Development of retinoblastoma in the absence of telomerase activity.
Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
[TBL] [Abstract][Full Text] [Related]
11. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
[TBL] [Abstract][Full Text] [Related]
12. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
13. Treating Cancer by Targeting Telomeres and Telomerase.
Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
Katayama S; Shiota G; Kawasaki H
Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
[TBL] [Abstract][Full Text] [Related]
15. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
Engelhardt M; Martens UM
Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in gastric cancer.
Hiyama E; Yokoyama T; Tatsumoto N; Hiyama K; Imamura Y; Murakami Y; Kodama T; Piatyszek MA; Shay JW; Matsuura Y
Cancer Res; 1995 Aug; 55(15):3258-62. PubMed ID: 7614459
[TBL] [Abstract][Full Text] [Related]
17. Telomerase and human tumorigenesis.
Stewart SA; Weinberg RA
Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
[TBL] [Abstract][Full Text] [Related]
18. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
19. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
20. Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
Ceja-Rangel HA; Sánchez-Suárez P; Castellanos-Juárez E; Peñaroja-Flores R; Arenas-Aranda DJ; Gariglio P; Benítez-Bribiesca L
Tumour Biol; 2016 Sep; 37(9):11917-11926. PubMed ID: 27072825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]